Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: BMC Cancer 13.388 (2013): 02.09.2013
- Schlagwort
-
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2013
- Beteiligte Personen und Organisationen
-
Schiffmann, Leif
Klautke, Gunther
Wedermann, Nicole
Gock, Michael
Prall, Friedrich
Fietkau, Rainer
Rau, Bettina
Klar, Ernst
- URN
-
urn:nbn:de:bvb:29-opus-49576
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schiffmann, Leif
- Klautke, Gunther
- Wedermann, Nicole
- Gock, Michael
- Prall, Friedrich
- Fietkau, Rainer
- Rau, Bettina
- Klar, Ernst
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2013
Ähnliche Objekte (12)
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
Significance of gut microbiota in prognosis of cancer therapy-induced rectal mucositis and treatment outcome
Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer
Complete pathological response after neoadjuvant short-course immunotherapy with Ipilimumab and Nivolumab in locally advanced MSI-H/dMMR rectal cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
Significance of gut microbiota in prognosis of cancer therapy-induced rectal mucositis and treatment outcome
Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer
Complete pathological response after neoadjuvant short-course immunotherapy with Ipilimumab and Nivolumab in locally advanced MSI-H/dMMR rectal cancer
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
Computertomography-based prediction of complete response following neoadjuvant chemoradiotherapy of locally advanced rectal cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI
Significance of gut microbiota in prognosis of cancer therapy-induced rectal mucositis and treatment outcome
Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer